FO
ZSAN

FT Options’s Zosano Pharma Corporation ZSAN Stock Holding History

FT Options’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$49K Hold
86
– – 0.07% 122
2017
Q2 		$85K Hold
86
– – 0.15% 93
2017
Q1 		$114K Buy
+86
New +$104K 0.15% 112

Other funds holding ZSAN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return

FT Options's ZSAN Position: Q3 2017 in Review

FT Options held its Zosano Pharma Corporation (ZSAN) position steady in Q3 2017 at 86 shares worth $49K. The position accounts for 0.07% of the portfolio, ranked #122.

FT Options first reported a position in ZSAN in Q1 2017 and has held it in 3 quarters since. The position peaked at $114K in Q1 2017. 22 funds tracked by Wall St. Rank hold ZSAN as of Q3 2017.

  • FT Options held 86 shares of Zosano Pharma Corporation worth $49K as of Q3 2017.
  • FT Options left its Zosano Pharma Corporation share count unchanged in Q3 2017.
  • Zosano Pharma Corporation made up 0.07% of FT Options's portfolio in Q3 2017, its #122 holding.
  • FT Options first reported a position in Zosano Pharma Corporation in Q1 2017 and has held it in 3 quarters since.
  • FT Options's Zosano Pharma Corporation position peaked at $114K in Q1 2017.
  • 22 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q3 2017.

Based on FT Options's 13F filing for Q3 2017, filed 13 Nov 2017.